果糖二磷酸钠对2型糖尿病血液流变学、SOD和LPO的影响.pdfVIP

! 412 ! (Chin J New Drugs Clin Rem) , 2001 11 , 20 6 f iliated H osp ital of Beij ing Medical Unirersity, qd) and fiftysix patients received benazepril ( 10 mg, BEIJING 100034, C ina; 3 . Dep artment of Car p o, qd) for 8wk. Another 33 patients in open trial diology, Union H osp ital, Wu an Tongj i Medical received doxazosin with 24 h ambulatory blood pres University, Wu an H UBEI 430022 , C ina) sure monitoring (ABPM) before and after treatment 4 mg, po , qd for 8 wk. RESULTS: The blood [KEY WORDS] doxazosin; benazepril; hyperten pressure significantly decreased after treatment with sion; blood pressure determination; blood pressure doxazosin and benazepril and the effective rates were monitors; randomized controlled trials; doubleblind 81% and 77 %, respectively at the end of 8wk. And method the adverse reactions were 3 % and 20 % with no or thostatic hypotension.24h ABPM showed significant [ABSTRACT] AIM: To evaluate the efficacy and ly daytime and nighttime blood pressure smoothly re safety of doxazosin controlled release tablets in pa duction and T/ P ratio: SBP: 0. 69, DBP: 0. 59. tients with mild to moderate essential hypertension. C NCLUSI N: Doxazosin controlled release tablets METH DS: A multicenter, doubleblind, double is an effective, safe and longacting 1receptor block similarly randomized parallel study was designed. er and has less adverse reaction than benazepril in Fiftyeight patients received doxazosin ( 4 mg, p o, treating mild to moderated essential hypertension. (Chin J New Drugs Clin Rem) , 2001 11 , 20(6) :412- 414. 2 SOD LPO 王 军, 张金盈 ( , 450052) [] 果糖二磷酸盐类; 果糖二磷酸钠; 非胰岛 [] 2001 素依赖型糖尿病; 血液流变学; 超氧化物歧化酶; 过 氧化脂质类 2